This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Burton J. Kushner, MD

Arch Ophthalmol. 1997;115(11):1458-1459.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

TO DO good research in the field of strabismus, one must think fourth dimensionally—the fourth dimension being time. One needs to know not only the short-term outcome of a given study, but also how those results hold up over time. Frequently manuscripts dealing with strabismus report data on patients who have been followed up for a short while after surgery; the reader never learns how those same patients fare as more time passes. Consequently, McNeer et al¹ are to be heartily congratulated for their article in this issue of the ARCHIVES. They report additional follow-up on a group of patients who were treated with bilateral botulinum toxin type A injections for infantile esotropia. (The initial report has been published.²) At first glance, the results they report seem good, so good in fact that the reader must answer the question: "Should botulinum toxin type A be the treatment of . . . [Full Text PDF of this Article]

Author Affiliations
Madison, Wis

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?